News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
AstraZeneca PLC’s Crestor Fails in New Heart-Failure Study
September 2, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUNICH, Aug 31 (Reuters) - AstraZeneca Plc's cholesterol drug Crestor has failed in a second clinical trial for heart failure, suggesting such statin medicines don't improve survival in patients with the chronic condition.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
AstraZeneca
MORE ON THIS TOPIC
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
·
2 min read
·
Gabrielle Masson
Duchenne muscular dystrophy
Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study
May 7, 2026
·
2 min read
·
Tristan Manalac
Insights
Fibrosis, IPF and the search for better therapies
May 7, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Business
CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026
May 6, 2026
·
1 min read
·
Gabrielle Masson
